RESUMO
Abstract Objective: To evaluate the diagnostic utility of salivary C-reactive protein (CRP) and its potential correlation with serum CRP levels in full-term neonates with late-onset sepsis (LOS). Methods: This cross-sectional study included 90 neonates assigned to three equal groups: culture proven LOS, clinical LOS and a control group. Clinical findings and routine laboratory data including complete blood pictures and blood culture results were documented. Highly sensitive serum CRP was measured according to hospital protocol, while salivary CRP levels were measured using enzyme-linked immunosorbent assay. Results: The median serum CRP was significantly higher in septic neonates compared to controls (p < 0.001). For serum CRP, the optimum cut-off value for LOS diagnosis was found to be 7.2 mg/L with sensitivity, specificity, positive and negative predictive values of 91, 100, 100, and 85.7%, respectively. No significant difference was observed in levels of salivary CRP among the 3 study groups (p = 0.39). No correlation was found between the levels of salivary and serum CRP (r = 0.074, p = 0.49). Conclusion: Serum CRP, at a cut-off value of 7.2 mg/L, exhibited a high specificity and positive predictive value in LOS diagnosis, whereas salivary CRP levels weren't significantly different between the 3 study groups nor did they predict abnormal serum CRP thresholds in newborns with sepsis.
Assuntos
Humanos , Recém-Nascido , Sepse/diagnóstico , Sepse Neonatal/diagnóstico , Proteína C-Reativa/análise , Biomarcadores , Estudos Transversais , Valor Preditivo dos Testes , Sensibilidade e EspecificidadeRESUMO
Objective To observe the clinical efficacy of butylphthalide in the treatment of acute cerebral infarction and its effect on serum C-reactive protein(CRP).Methods A total of 120 inpatients with acute cerebral infarction were randomly assigned into control group (n =60) and observation group (n =60) by the digital table method.The control group was treated with Xueshuantong injection,inhibiting blood platelet and improving brain metabolism.The observation group was treated with butylphthalide based on the treatment of the control group.The changes in serum CRP and clinical efficacy were compared between the two groups 2 weeks after treatment.Results After treatment,the CRP level was decreased greatly in the observation group,but the CRP level was reduced slightly in the control group compared with before treatment,the CRP level in the observation group was (2.54 ± 0.79) mg/L,which was significantly lower than (5.66 ± 1.78) mg/L in the control group (t =12.41,P ＜ 0.05).The total effective rate in the observation group was 75.00％,which was significantly higher than 53.33％ in the control group (x2 =6.13,P ＜ 0.05).The 3-day NIHSS score [(8.62 ± 1.89) points],1-week NIHSS score [(4.21 ± 1.76) points],and 2-week NIHSS score [(5.79 ± 1.36) points] after treatment were significantly lower in the observation group compared with the control group (t =2.84,11.93,6.67,all P ＜ 0.05).Conclusion Based on conventional treatment,butylphthalide injection in the treatment of acute cerebral infarction can remarkably reduce CRP level,alleviate inflammatory reactions,improve cerebral infarction condition and prognosis,exert obvious effect and it is worthy of clinical promotion.
RESUMO
Objective To study curative efficacy of Pramipexole in treatment of Parkinson's Disease and its effects on Serum C-reactionprotein (CRP), cystatin C, brain derived neurotrophic factor(BDNF) and oxidative stress.Methods 100 patients of Parkinson's Disease who received therapy from February 2014 to April 2016 in our hospital were selected as research objects were randomLy divided into control group and observation group, 50 patients in each group.The control group was treated with Dobasidate tablets;The observation group was given pramipexole tablets on the basis of the control group.Then the clinical effects and adverse reactions were compared.CRP, Cystatin C, BDNF and oxidative stress were measured. Results After treatment, the total effective rate of the observation group [(90.00% (45/50)] was significantly higher than the control group[74.00%(37/50)] (P<0.05);The symptoms of palpitation, depression, nausea, anorexia, diarrhea and vomiting were lower in observation group than in observation group, and the differences of depression, anorexia and vomiting were statistically significant(P<0.05);The BDNF index of the observation group (13.38 ±1.93)ng/L was higher than that of the control group (12.03 ±1.83) ng/L(P<0.05);CRP (3.53 ±0.97) mg/L and Cystatin C index (0.98 ±0.12) mg/L were lower than the control group(4.62 ±1.15)、(1.06 ±0.14) mg/L (P<0.05).After treatment, the glutathione peroxidate (GPX),superroxide dismutase(SOD),glutathione(GSH)and catalase(CAT) of oxidative stress in observation group were higher than those in control group,the difference was statistically significant (P<0.05).Conclusion Pramipexole in the treatment of Parkinson's disease is obvious, can effectively improve the serum CRP, Cystatin C and BDNF index, high security, it is worth promoting the application.
RESUMO
Objective To investigate the effect of alprostadil injection on serum CRP, IL-6 and TNF-alpha and prognosis in patients with acute cerebral infarction.Methods 80 cases of patients with acute cerebral infarction from February 2014 to February 2016 in Ningbo Yinzhou People's Hospital were selected,all patients were randomly divided into two groups, the control group 40 cases, the conventional treatment of acute cerebral infarction;40 cases in the observation group, with alprostadil injection on the basis of control group.The levels of serum CRP, IL-6 and TNF-αwere observed before and after treatment, and the NIHSS and Barthel index score and the curative effect after treatment were observed.Results Compared with before treatment, no significant change after treatment of serum CRP, IL-6 and TNF-αlevels in the control group,the serum CRP, IL-6 and TNF-αlevels decreased significantly in the observation group ( P <0.05 ) , and significantly lower than the control group ( P <0.05 ).Compared with before treatment, NIHSS score decreased after treatment in two groups (P <0.05),Barthel index (P <0.05) score increased, NIHSS score in observation group was significantly lower than the control group (P<0.05), Barthel index score was significantly higher than the control group (P<0.05).After treatment,the effective rate of the observation group was 95%, which was significantly higher than that of the control group 72.5% ( P <0.05 ) . Conclusion Alprostadil injection treatment of acute cerebral infarction, can effectively reduce the patient's serum CRP, IL-6 and TNF-αlevels, reduce brain damage, can improve the curative effect, improve the prognosis.
RESUMO
Objective To investigate the influence of three kinds of different Ca~(2+) concentration of dialysate on serum calcium,calcium-phosphorus product,serum PTH and CRP in maintenance hemodialysis patients.Methods 45 patients of maintenance hemodialysis with ages ≥18 years were selected.They were divided randomly three groups,and be given three different kinds of Ca~(2+) concentration of dialysate to carry out hemodialysis with 3 months.Then the patients' variation of blood pressure and whether there were low calcium spasm or ostealgia were abserved during hemodialysis whole range.In addition,changes of their serum calcium、phosphorus、iPTH and CRP at pretherapy and three months after reatment were also detected.Results After three months of hemodialysis,serum iPTH in patients with low Ca~(2+) concentration dialysate increased obviously,and the serum CRP decreased significantly(P0.05),and serum CRP increase notably(P